Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Lessons from COVAX could help vaccine equity

COVAX was supposed to be the elixir for vaccine inequality - it wasn’t. However, lessons can be taken from previous global experiences to help make progress, writes Putri Widi Saraswati.

Newsroom.co.nz

If You Invested $1,000 In BioNTech Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Trial results of 'moon shot' Covid-19 vaccine that 'protects against all variants' expected in coming days

Results of the trial on the single-shot jab are expected in the coming days.

Dublin Live

From analysis to the latest developments in health,
read the most diverse news in one place.

Govt receives 200k Covovax dose lift

The Ministry of Public Health will distribute 200,000 coronavirus protein-based vaccine doses donated by India and its partners to state-owned hospitals across Thailand with the target of inoculating those unvaccinated people.

Bangkok Post

Waiting longer between Covid jabs 'could generate up to nine times more antibodies'

Antibody levels in blood samples taken from almost 6,000 healthcare workers from across the UK were measured

Wales Online

CPS employee vaccine mandate reinstated by Illinois appellate court

The downstate court’s decision represents a win for CPS and lets officials resume enforcing their vaccine mandate while a lawsuit challenging the policy plays out.

Chicago Sun-Times

Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains

Celsion Corporation (NASDAQ:CLSN) has presented its PLACCINE platform technology at the World Vaccine Congress. "PLACCINE is demonstrating the potential to be a powerful platform that provides for rapid design capability for targeting two or more different variants of a single virus in one vaccine," said Dr. Khursheed Anwer, Chief Science Officer at Celsion.…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Covid-19 Ireland: People aged 65 and over eligible for second booster vaccine

The online portal to register for a second booster opens today

Dublin Live

If You Invested $1,000 In Pfizer Stock At Its Pandemic Low, Here's How Much You'd Have Now

Benzinga

Government panel recommends emergency use authorisation for Corbevax for 5-11 age group

The Subject Expert Committee has also recommended the grant of EUA to Cadila for their ZyCoV-D vaccine

The Hindu

NSW employers can still require staff Covid jabs, despite end of most mandates, say workplace lawyers

Vaccine mandates will remain in place for now in Victoria as authorities work with individual industries

The Guardian - AU

More funding needed for rollout of highly effective malaria vaccine, Oxford chief warns

‘It seems extraordinary after the worst pandemic we’ve had in a century ... we can’t find the money to get Africa out of the horrendous mortality that it’s been suffering from malaria,’ says Professor Adrian Hill

The Independent UK

‘Moon shot’ Covid vaccine that works against all variants hailed by Prof Luke O’Neill

Test results on animals have been 'impressive', according to the professor of biochemistry at Trinity College, who expects data from the phase one trial on humans to be published 'any day now'

Irish Mirror

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study

The study compared immune responses to seven vaccines used as a booster 28 days after two initial doses.

Benzinga

Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies

Codiak BioSciences Inc (NASDAQ:CDAK) announced new preclinical data from its pan beta-coronavirus vaccine program. The data demonstrate the potential for the vaccine candidate to induce cross-neutralizing antibody protection against multiple strains and an antigen-specific & immune response against structurally conserved regions of various coronavirus variants. Preclinical data showed a durable antibody response lasting…

The Guardian - UK

Globalisation is not working – in an age of insecurity, we need more local solutions

From the supply-chain crisis to Covid vaccines, the past couple of years have brought home the benefits of self-sufficiency, says the Guardian’s economics editor, Larry Elliott

The Guardian - UK

Best podcasts of the week: How Covid conspiracists ‘killed off’ Tiffany Dover

In this week’s newsletter: an American nurse sent anti-vaxxers into a frenzy after fainting on TV after her vaccine – NBC’s Brandy Zadrozny finds out why. Plus: five podcasts to help you find love

Get all your
news in one place.

100’s of premium titles.
One news app.

Newsroom.co.nz

Defence Force staff face dismissal over vaccine mandate

A legal challenge seems likely as the military holds firm on a Covid vaccine requirement.

Newsroom.co.nz

Employers urged to hold off on deleting vaccine records

An employment lawyer is challenging advice to bosses to erase staff vaccination data, saying deleting this information is the last thing employers want to be doing.

360info

Special Report: Vaccines beyond COVID

For WHO Immunisation Week, we explore what could drive the next great leap forward on vaccines.

360info

In mRNA we trust

The mRNA vaccines developed to fight COVID were found to be safe and effective, even for pregnant women, inspiring scientists to explore their potential.

360info

Computer modelling to aid search for HIV vaccine

The search continues at a brisk pace thanks to rapid developments in generating more potent computing power.

360info

Can we improve on a once-in-a-century TB vaccine?

It has been over 100 years since the last licensed tuberculosis vaccine. The clock is ticking to find a new one.

360info

Paving the way for a global malaria vaccine

Malaria impacts India more than anywhere else in southeast Asia, but relief could be on the way if the early promise of vaccines in development is fulfilled.

1 … 262 263 264 265

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.